vs

Side-by-side financial comparison of Emerson Electric (EMR) and NetEase, Inc. (NTES). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $4.0B, roughly 1.1× NetEase, Inc.). NetEase, Inc. runs the higher net margin — 31.0% vs 13.9%, a 17.1% gap on every dollar of revenue. NetEase, Inc. produced more free cash flow last quarter ($1.8B vs $602.0M). Over the past eight quarters, NetEase, Inc.'s revenue compounded faster (9.7% CAGR vs -0.3%).

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

NetEase, Inc. is a Chinese developer and publisher of online PC and mobile games, advertising services, email services, and e-commerce platforms. It is one of the largest Internet and video game companies in the world and was founded by Ding Lei in June 1997.

EMR vs NTES — Head-to-Head

Bigger by revenue
EMR
EMR
1.1× larger
EMR
$4.3B
$4.0B
NTES
Higher net margin
NTES
NTES
17.1% more per $
NTES
31.0%
13.9%
EMR
More free cash flow
NTES
NTES
$1.2B more FCF
NTES
$1.8B
$602.0M
EMR
Faster 2-yr revenue CAGR
NTES
NTES
Annualised
NTES
9.7%
-0.3%
EMR

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
EMR
EMR
NTES
NTES
Revenue
$4.3B
$4.0B
Net Profit
$605.0M
$1.2B
Gross Margin
53.2%
64.1%
Operating Margin
17.8%
28.3%
Net Margin
13.9%
31.0%
Revenue YoY
4.1%
Net Profit YoY
3.4%
EPS (diluted)
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMR
EMR
NTES
NTES
Q4 25
$4.3B
Q3 25
$4.9B
$4.0B
Q2 25
$4.6B
$3.9B
Q1 25
$4.4B
$4.0B
Q4 24
$4.2B
Q3 24
$4.6B
$3.7B
Q2 24
$4.4B
$3.5B
Q1 24
$4.4B
$3.7B
Net Profit
EMR
EMR
NTES
NTES
Q4 25
$605.0M
Q3 25
$637.0M
$1.2B
Q2 25
$586.0M
$1.3B
Q1 25
$485.0M
$1.5B
Q4 24
$585.0M
Q3 24
$996.0M
$955.7M
Q2 24
$329.0M
$939.6M
Q1 24
$501.0M
$1.1B
Gross Margin
EMR
EMR
NTES
NTES
Q4 25
53.2%
Q3 25
51.9%
64.1%
Q2 25
52.6%
64.7%
Q1 25
53.5%
64.1%
Q4 24
53.5%
Q3 24
51.3%
62.9%
Q2 24
52.8%
62.9%
Q1 24
52.2%
63.4%
Operating Margin
EMR
EMR
NTES
NTES
Q4 25
17.8%
Q3 25
16.4%
28.3%
Q2 25
16.1%
32.5%
Q1 25
14.2%
36.2%
Q4 24
18.6%
Q3 24
14.7%
27.3%
Q2 24
10.4%
27.4%
Q1 24
16.2%
28.4%
Net Margin
EMR
EMR
NTES
NTES
Q4 25
13.9%
Q3 25
13.1%
31.0%
Q2 25
12.9%
32.6%
Q1 25
10.9%
36.6%
Q4 24
14.0%
Q3 24
21.6%
25.6%
Q2 24
7.5%
26.8%
Q1 24
11.4%
29.1%
EPS (diluted)
EMR
EMR
NTES
NTES
Q4 25
$1.07
Q3 25
$1.12
Q2 25
$1.04
Q1 25
$0.86
Q4 24
$1.02
Q3 24
$1.74
Q2 24
$0.57
Q1 24
$0.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMR
EMR
NTES
NTES
Cash + ST InvestmentsLiquidity on hand
$31.3B
Total DebtLower is stronger
$7.6B
Stockholders' EquityBook value
$20.3B
$160.8B
Total Assets
$41.9B
$214.5B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EMR
EMR
NTES
NTES
Q4 25
Q3 25
$31.3B
Q2 25
$54.4B
Q1 25
$41.7B
Q4 24
Q3 24
$20.2B
Q2 24
$19.0B
Q1 24
$43.0B
Total Debt
EMR
EMR
NTES
NTES
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Q1 24
$7.6B
Stockholders' Equity
EMR
EMR
NTES
NTES
Q4 25
$20.3B
Q3 25
$20.3B
$160.8B
Q2 25
$19.9B
$154.0B
Q1 25
$19.2B
$147.8B
Q4 24
$20.5B
Q3 24
$21.6B
$135.6B
Q2 24
$20.8B
$134.2B
Q1 24
$20.9B
$130.5B
Total Assets
EMR
EMR
NTES
NTES
Q4 25
$41.9B
Q3 25
$42.0B
$214.5B
Q2 25
$42.5B
$208.5B
Q1 25
$42.0B
$200.9B
Q4 24
$42.6B
Q3 24
$44.2B
$184.9B
Q2 24
$45.6B
$183.3B
Q1 24
$46.4B
$195.1B
Debt / Equity
EMR
EMR
NTES
NTES
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMR
EMR
NTES
NTES
Operating Cash FlowLast quarter
$699.0M
$1.8B
Free Cash FlowOCF − Capex
$602.0M
$1.8B
FCF MarginFCF / Revenue
13.9%
44.7%
Capex IntensityCapex / Revenue
2.2%
1.0%
Cash ConversionOCF / Net Profit
1.16×
1.47×
TTM Free Cash FlowTrailing 4 quarters
$4.4B
$6.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMR
EMR
NTES
NTES
Q4 25
$699.0M
Q3 25
$3.1B
$1.8B
Q2 25
$1.1B
$1.5B
Q1 25
$241.0M
$1.7B
Q4 24
$777.0M
Q3 24
$3.3B
$1.5B
Q2 24
$1.1B
$898.8M
Q1 24
$743.0M
$1.3B
Free Cash Flow
EMR
EMR
NTES
NTES
Q4 25
$602.0M
Q3 25
$2.7B
$1.8B
Q2 25
$977.0M
$1.5B
Q1 25
$154.0M
$1.6B
Q4 24
$694.0M
Q3 24
$2.9B
$1.5B
Q2 24
$998.0M
$875.6M
Q1 24
$661.0M
$1.3B
FCF Margin
EMR
EMR
NTES
NTES
Q4 25
13.9%
Q3 25
54.9%
44.7%
Q2 25
21.5%
38.3%
Q1 25
3.5%
40.4%
Q4 24
16.6%
Q3 24
63.1%
38.9%
Q2 24
22.8%
25.0%
Q1 24
15.1%
34.0%
Capex Intensity
EMR
EMR
NTES
NTES
Q4 25
2.2%
Q3 25
8.9%
1.0%
Q2 25
2.0%
0.7%
Q1 25
2.0%
1.6%
Q4 24
2.0%
Q3 24
9.1%
1.4%
Q2 24
2.1%
0.7%
Q1 24
1.9%
1.5%
Cash Conversion
EMR
EMR
NTES
NTES
Q4 25
1.16×
Q3 25
4.86×
1.47×
Q2 25
1.83×
1.20×
Q1 25
0.50×
1.15×
Q4 24
1.33×
Q3 24
3.35×
1.58×
Q2 24
3.31×
0.96×
Q1 24
1.48×
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

NTES
NTES

Games and related value-added services$3.3B82%
NetEase Cloud Music$275.9M7%
Youdao$228.8M6%
Innovative businesses and others$202.1M5%

Related Comparisons